ISSN: 2167-7948
+44 1300 500008
Department of Head and Neck Surgery, National Institute of Oncology, Budapest, Hungary
Dr. Mahtab Ferenc is a distinguished surgeon specializing in head and neck oncology at the National Institute of Oncology in Budapest, Hungary. This premier institution serves as Hungary's central hub for cancer treatment, research, and education, coordinating national oncology efforts and maintaining international collaborations to integrate Hungarian oncology into the global medical community. In 2021, Dr. Ferenc authored a significant short communication titled "A Note on Thyroid Disease Malignancy," published in the Journal of Thyroid Disorders & Therapy. This work delves into the genetic foundations of thyroid cancers, discussing how mutations in specific genes can lead to malignancies. The paper emphasizes the importance of genetic testing, particularly for mutations in the RET oncogene, in the management of medullary thyroid carcinoma. Dr. Ferenc's insights contribute to a deeper understanding of thyroid cancer pathogenesis and underscore the role of genetics in both diagnosis and treatment. Beyond his contributions to thyroid oncology, Dr. Ferenc is actively involved in advancing surgical techniques and treatment protocols for various head and neck cancers. His commitment to integrating research findings into clinical practice enhances patient outcomes and aligns with the National Institute of Oncology's mission to provide comprehensive cancer care. Dr. Ferenc's dedication to oncology is further reflected in his participation in professional organizations and conferences, where he collaborates with peers to share knowledge and promote advancements in cancer treatment. His ongoing research and clinical efforts continue to make a significant impact on the field of head and neck oncology, both nationally and internationally.
Short Communication
A Note on Thyroid Disease Malignancy
Author(s): Mahtab Ferenc*
Disclosures made during the beyond twenty years have upset comprehension of the hereditary premise of human disease. Diseases start from single forerunner cells, which bring about clones that extend through securing of changes that modify the capacity of qualities significant in the control of cell development and endurance. Now and again, one of these freak qualities might be acquired in the germ line, inclining the person to familial malignant growth conditions. All the more generally, transformations grow postnatally over the span of growth development. Numerous growth types have genuinely trademark hereditary imperfections, which give freedoms to utilize hereditary data for family advising, determination, or forecast. In thyroid malignant growth, hereditary testing for transformations of the RET oncogene has profoundly affected the administration of Medullary Thyroid Carcinoma (MT.. View More»
DOI:
10.35248/2167-7948.21.10.260
https://hcn.eu/partner/national-institute-oncology-hungary/?utm_source=chatgpt.com